|
CA2790034A1
(en)
|
2001-06-21 |
2003-01-03 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of superoxide dismutase 1, soluble expression
|
|
US20050019915A1
(en)
*
|
2001-06-21 |
2005-01-27 |
Bennett C. Frank |
Antisense modulation of superoxide dismutase 1, soluble expression
|
|
SI2548560T1
(sl)
|
2005-06-23 |
2015-12-31 |
Isis Pharmaceuticals, Inc. |
Sestavki in postopki za moduliranje izrezovanja smn2
|
|
WO2008127974A1
(en)
|
2007-04-13 |
2008-10-23 |
The Trustees Of Columbia University In The City Of New York |
Stem cell-based culture system for drug development
|
|
JP5879256B2
(ja)
|
2009-05-02 |
2016-03-08 |
ジェンザイム・コーポレーション |
神経変性障害のための遺伝子治療
|
|
PT3305302T
(pt)
|
2009-06-17 |
2018-12-14 |
Biogen Ma Inc |
Composições e métodos de modulação de excisões de smn2 em um sujeito
|
|
US8465727B2
(en)
|
2009-10-06 |
2013-06-18 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Biomarkers for the diagnosis of ALS
|
|
CA2872190C
(en)
|
2012-05-09 |
2024-06-25 |
Karyopharm Therapeutics, Inc. |
Nuclear transport modulators and uses thereof
|
|
ES2762326T5
(es)
|
2012-10-15 |
2023-04-27 |
Ionis Pharmaceuticals Inc |
Métodos para modular la expresión de C9ORF72
|
|
HK1212597A1
(zh)
|
2012-10-15 |
2016-06-17 |
Isis Pharmaceuticals, Inc. |
用於調節c90rf72表達的組合物
|
|
WO2014062736A1
(en)
|
2012-10-15 |
2014-04-24 |
Isis Pharmaceuticals, Inc. |
Methods for monitoring c9orf72 expression
|
|
WO2014065341A1
(ja)
|
2012-10-24 |
2014-05-01 |
第一三共株式会社 |
筋萎縮性側索硬化症治療剤
|
|
EP2943225A4
(en)
|
2013-01-09 |
2016-07-13 |
Ionis Pharmaceuticals Inc |
COMPOSITIONS AND METHODS FOR MODULATING SMN2 DISTRIBUTION IN THE BODY OF A PATIENT
|
|
EP4166667A3
(en)
|
2013-10-11 |
2023-08-02 |
Ionis Pharmaceuticals, Inc. |
Compositions for modulating c9orf72 expression
|
|
US20160230172A1
(en)
|
2013-10-14 |
2016-08-11 |
Ionis Pharmaceuticals, Inc. |
Compositions for modulating expression of c9orf72 antisense transcript
|
|
AU2014337506B2
(en)
|
2013-10-14 |
2020-10-15 |
Ionis Pharmaceuticals, Inc. |
Methods for modulating expression of C9ORF72 antisense transcript
|
|
WO2015143245A1
(en)
|
2014-03-19 |
2015-09-24 |
Isis Pharmaceuticals, Inc. |
Methods for modulating ataxin 2 expression
|
|
CN106103717A
(zh)
|
2014-03-19 |
2016-11-09 |
Ionis制药公司 |
用于调节共济失调蛋白2表达的组合物
|
|
RS60707B1
(sr)
*
|
2014-04-01 |
2020-09-30 |
Biogen Ma Inc |
Kompozicije za modulaciju ekspresije sod-1
|
|
US10024870B2
(en)
|
2014-04-02 |
2018-07-17 |
Wisconsin Alumni Research Foundation |
Therapeutic and diagnostic methods and compositions for neurodegenerative diseases
|
|
WO2015161170A2
(en)
|
2014-04-17 |
2015-10-22 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for modulation of smn2 splicing in a subject
|
|
BR112017004056A2
(pt)
|
2014-09-12 |
2017-12-05 |
Biogen Ma Inc |
composições e métodos para detecção da proteína smn em um indivíduo e tratamento de um indivíduo
|
|
KR20230104759A
(ko)
|
2014-09-30 |
2023-07-10 |
뉴리뮨 홀딩 아게 |
인간-유래의 항-디펩티드 반복체(dpr) 항체
|
|
CA3193811A1
(en)
|
2014-11-14 |
2016-05-19 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating amyotrophic lateral sclerosis (als)
|
|
WO2016112132A1
(en)
|
2015-01-06 |
2016-07-14 |
Ionis Pharmaceuticals, Inc. |
Compositions for modulating expression of c9orf72 antisense transcript
|
|
WO2016167780A1
(en)
|
2015-04-16 |
2016-10-20 |
Ionis Pharmaceuticals, Inc. |
Compositions for modulating expression of c9orf72 antisense transcript
|
|
RS60230B1
(sr)
|
2015-04-16 |
2020-06-30 |
Ionis Pharmaceuticals Inc |
Kompozicije za moduliranje ekspresije c9orf72
|
|
US11260073B2
(en)
|
2015-11-02 |
2022-03-01 |
Ionis Pharmaceuticals, Inc. |
Compounds and methods for modulating C90RF72
|
|
US20190002887A1
(en)
|
2015-12-31 |
2019-01-03 |
Ionis Pharmaceuticals, Inc. |
Methods for reducing ataxin-2 expression
|
|
AU2017248637A1
(en)
|
2016-04-13 |
2018-09-27 |
Ionis Pharmaceuticals, Inc. |
Methods for reducing C9ORF72 expression
|
|
WO2018218219A1
(en)
|
2017-05-26 |
2018-11-29 |
University Of Miami |
Determining onset of amyotrophic lateral sclerosis
|
|
TW201920672A
(zh)
|
2017-08-08 |
2019-06-01 |
新加坡商波濤生命科學有限公司 |
寡核苷酸組合物及其使用方法
|
|
TW202413649A
(zh)
|
2017-10-16 |
2024-04-01 |
美商航海家醫療公司 |
肌萎縮性脊髓側索硬化症(als)之治療
|
|
SG11202006677XA
(en)
|
2018-01-25 |
2020-08-28 |
Biogen Ma Inc |
Methods of treating spinal muscular atrophy
|
|
EA201992364A1
(ru)
|
2018-04-02 |
2020-03-23 |
Кохерус Байосайенсис Инк. |
АГОНИСТ PPARγ ДЛЯ ЛЕЧЕНИЯ ПРОГРЕССИРУЮЩЕГО НАДЪЯДЕРНОГО ПАРАЛИЧА
|
|
BR112020021855A2
(pt)
|
2018-04-27 |
2021-02-23 |
Biogen Ma Inc. |
anticorpo antirrepetição de dipeptídeo (dpr) (poli-ga) derivado de humanos
|
|
WO2020061355A2
(en)
|
2018-09-20 |
2020-03-26 |
Biogen Ma Inc. |
Serum neurofilament protein for guiding therapeutic intervention in multiple sclerosis
|
|
MA54383A
(fr)
|
2018-12-06 |
2021-10-13 |
Biogen Ma Inc |
Protéine neurofilamenteuse pour guider une intervention thérapeutique dans la sclérose laterale amyotrophique
|
|
TWI906204B
(zh)
|
2018-12-14 |
2025-12-01 |
美商百健Ｍａ公司 |
用於治療及預防肌肉萎縮性脊髓側索硬化症之組合物及方法
|
|
MA54949A
(fr)
|
2019-02-12 |
2021-12-22 |
Biogen Ma Inc |
Biomarqueurs de la leucoencéphalopathie multifocale progressive
|